Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 173
interventional 159
Observational 13
Registry 1

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 69
Drug|placebo 23
Device 16
Biological 13
Dietary Supplement|placebo 7
Device|Drug 5
Other 5
Drug|Other 4
Behavioral 2
Dietary Supplement 2
Dietary Supplement|Other|placebo 2
Procedure 2
Biological|Device|Drug 1
Biological|Other 1
Device|Diagnostic Test|Drug 1
Device|Other 1
Device|Procedure 1
Diagnostic Test|Drug|Procedure 1
Drug|Radiation 1
Other|placebo 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 86
NA 10
Egypt 8
Canada 5
Korea, Republic of 4
Australia 3
Germany 3
Thailand 3
United Kingdom 3
France 2
Switzerland 2
Taiwan 2
United States|Canada 2
Argentina|Chile|Japan|Mexico|Peru|Philippines|Russian Federation|Taiwan|Thailand 1
Belgium|Germany|Hungary|Russian Federation|Spain 1
Chile|Hong Kong|Korea, Republic of|Singapore|Taiwan 1
China 1
France|Germany 1
Georgia 1
Greece 1
India 1
Iran, Islamic Republic of 1
Israel 1
Italy 1
Japan 1
Pakistan 1
Russian Federation 1
Saudi Arabia 1
Spain 1
Turkey 1
United States|Argentina|Australia|Brazil|China|Israel|Japan|Korea, Republic of|Puerto Rico|Taiwan 1
United States|Argentina|Australia|Canada|Chile|China|Colombia|Czechia|Germany|Hungary|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Canada|Colombia|Japan|Korea, Republic of|Mexico|Russian Federation|Taiwan 1
United States|Australia|Canada 1
United States|Brazil 1
United States|Canada|France|Germany|United Kingdom 1
United States|France|Germany|United Kingdom 1
United States|Germany 1
United States|Japan|Korea, Republic of|Mexico|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 96
2 19
3 9
4 6
5 3
6 3
7 3
9 1
10 1
12 2
13 1
14 1
15 1
17 1
18 2
24 1
25 2
39 1
46 1
55 1
76 1
86 1
101 1
153 1

Phase

Phase Study_Count
Phase 2 52
N/A 47
Phase 3 20
Phase 4 19
Phase 1 8
Phase 2/Phase 3 6
Early Phase 1 4
Phase 1/Phase 2 3

Number of Arms

Number_of_Arms Count_of_Studies
1 42
2 70
3 18
4 12
5 2
7 2
NA 13

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.00 5.00000 11.00 19.0 1.00000 20.0000 10.00 16.00000
1st Qu. 17.50 23.25000 13.50 19.5 30.50000 59.5000 43.25 20.00000
Median 22.50 54.50000 32.50 20.0 43.00000 362.5000 136.50 40.00000
Mean 20.75 59.06522 29.75 33.0 70.19608 362.6667 253.60 51.68421
3rd Qu. 25.75 73.50000 37.50 40.0 83.50000 651.2500 367.25 55.00000
Max. 28.00 239.00000 58.00 60.0 310.00000 725.0000 917.00 250.00000

Trial Group Type

group_type Group_Count
Experimental 148
Active Comparator 83
Placebo Comparator 59
NA 13
Other 8
No Intervention 5
Sham Comparator 5

Intervention Model

intervention_model Study_Count
Parallel Assignment 91
Single Group Assignment 56
Crossover Assignment 6
Factorial Assignment 2
Sequential Assignment 2
NA 2

Primary Purpose

primary_purpose Study_Count
Treatment 140
Other 5
Supportive Care 5
Basic Science 3
Prevention 2
Screening 2
Diagnostic 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 8
Egypt 2
United States|Australia|India|Italy 2
Korea, Republic of 1

Sites per Study

Site_count Study_Count
1 10
5 3

Enrollment Metrics

Measure Observational
Min 8
1st Qu 25
Median 200
Mean 1964
3rd Qu 700
Max 20000

Observation Model

observational_model Study_Count
Case-Control 7
Case-Only 2
Cohort 2
Other 2

Time Perspective

time_perspective Study_Count
Prospective 6
Cross-Sectional 4
Retrospective 2
Other 1

Registries

Studies by Country

Country Study_Count
United States 1

Sites per Study

Site_count Study_Count
1 1

Enrollment Metrics

Measure Registries
Min 34
1st Qu 34
Median 34
Mean 34
3rd Qu 34
Max 34

Registry Model

observational_model Study_Count
Case-Only 1

Time Perspective

time_perspective Study_Count
Cross-Sectional 1

Follow-up

target_duration Study_Count
1 Year 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03346668 Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia https://ClinicalTrials.gov/show/NCT03346668 Recruiting University of Minnesota 2020-08-01
NCT04459650 A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer https://ClinicalTrials.gov/show/NCT04459650 Recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT03732807 PF-06651600 for the Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT03732807 Recruiting Pfizer 2020-09-18
NCT03359356 Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) https://ClinicalTrials.gov/show/NCT03359356 Active, not recruiting Icahn School of Medicine at Mount Sinai 2020-12-31
NCT03331003 “iRestore” Light Therapy Apparatus https://ClinicalTrials.gov/show/NCT03331003 Completed National Taiwan University Hospital 2016-12-15
NCT03240627 Efficacy and Safety of LH-8 in Paediatric Alopecia Areata https://ClinicalTrials.gov/show/NCT03240627 Recruiting Legacy Healthcare SA 2020-02-01
NCT03206567 Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair https://ClinicalTrials.gov/show/NCT03206567 Completed Ablon Skin Institute Research Center 2017-12-10
NCT03078686 Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata https://ClinicalTrials.gov/show/NCT03078686 Recruiting Regeneris Medical 2025-01-22
NCT03052413 Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females https://ClinicalTrials.gov/show/NCT03052413 Completed Sadick Research Group 2017-11-10
NCT03004469 Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT03004469 Completed Polichem S.A. 2018-03-05
NCT02974868 Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata https://ClinicalTrials.gov/show/NCT02974868 Completed Pfizer 2019-05-15
NCT02919735 Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN) https://ClinicalTrials.gov/show/NCT02919735 Completed Legacy Healthcare SA 2018-07-31
NCT02865421 Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT02865421 Completed King Edward Medical University 2017-08-12
NCT02848300 Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT02848300 Completed Allergan 2016-10-31
NCT02824380 Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia https://ClinicalTrials.gov/show/NCT02824380 Completed Dong-A ST Co., Ltd. 2016-10-31
NCT02812342 Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants https://ClinicalTrials.gov/show/NCT02812342 Completed Yale University 2018-07-31
NCT02791243 Photosensitization Study in Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT02791243 Completed Polichem S.A. 2016-06-30
NCT02781311 A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males https://ClinicalTrials.gov/show/NCT02781311 Completed Allergan 2018-03-15
NCT02729415 Point-of-Care Adipose-derived Cells for Hair Growth https://ClinicalTrials.gov/show/NCT02729415 Completed University of Florida 2019-01-31
NCT02684097 A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata https://ClinicalTrials.gov/show/NCT02684097 Completed Icahn School of Medicine at Mount Sinai 2017-11-28
NCT02626780 Adipose-derived SVF for Treatment of Alopecia https://ClinicalTrials.gov/show/NCT02626780 Completed GID BIO, Inc. 2017-01-22
NCT02594046 The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia https://ClinicalTrials.gov/show/NCT02594046 Completed Pusan National University Hospital 2016-02-28
NCT02591355 Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment https://ClinicalTrials.gov/show/NCT02591355 Completed Regen Lab SA 2019-11-18
NCT03315689 Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT) https://ClinicalTrials.gov/show/NCT03315689 Completed Aclaris Therapeutics, Inc. 2019-06-20
NCT03137381 Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata https://ClinicalTrials.gov/show/NCT03137381 Completed Concert Pharmaceuticals 2019-07-08
NCT02561585 LEO 124249 Ointment in the Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT02561585 Completed LEO Pharma 2016-12-31
NCT02557074 TREg Activation in the Treatment of the PELADE (Alopecia Areata) https://ClinicalTrials.gov/show/NCT02557074 Completed Centre Hospitalier Universitaire de Nice 2019-02-02
NCT03388840 Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction https://ClinicalTrials.gov/show/NCT03388840 Recruiting Assiut University 2021-01-31
NCT02503852 STYLE – A Trial of Cell Enriched Adipose For Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT02503852 Completed Kerastem Technologies, LLC 2018-03-02
NCT02503137 A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing https://ClinicalTrials.gov/show/NCT02503137 Completed Samumed LLC 2016-04-30
NCT02460497 Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia https://ClinicalTrials.gov/show/NCT02460497 Completed Galderma Laboratories, L.P. 2015-11-30
NCT02460289 Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia https://ClinicalTrials.gov/show/NCT02460289 Completed Galderma Laboratories, L.P. 2015-11-30
NCT02312882 Tofacitinib for the Treatment of Alopecia Areata and Its Variants https://ClinicalTrials.gov/show/NCT02312882 Completed Stanford University 2015-08-31
NCT02302053 Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning Hair https://ClinicalTrials.gov/show/NCT02302053 Completed Ablon Skin Institute Research Center 2014-02-28
NCT02299297 Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis https://ClinicalTrials.gov/show/NCT02299297 Completed Columbia University 2017-12-31
NCT02297360 Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair https://ClinicalTrials.gov/show/NCT02297360 Completed Ablon Skin Institute Research Center 2014-04-30
NCT02288858 To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair https://ClinicalTrials.gov/show/NCT02288858 Completed Irish Response t/a Lifes2good 2011-11-30
NCT02280603 Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application https://ClinicalTrials.gov/show/NCT02280603 Completed Dong-A ST Co., Ltd. 2014-12-31
NCT02279823 A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT02279823 Completed Intrepid Therapeutics, Inc. 2015-12-31
NCT02275351 A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) https://ClinicalTrials.gov/show/NCT02275351 Completed Samumed LLC 2015-11-30
NCT02197455 Tofacitnib for the Treatment of Alopecia Areata and Variants https://ClinicalTrials.gov/show/NCT02197455 Completed Yale University 2015-07-31
NCT02170662 Topical Bimatoprost Effect on Androgen Dependent Hair Follicles https://ClinicalTrials.gov/show/NCT02170662 Completed Duke University 2011-05-31
NCT02150187 Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss https://ClinicalTrials.gov/show/NCT02150187 Completed Family Marketing 2015-02-28
NCT02087319 Effect of PRP on the Therapy for Hair Growth https://ClinicalTrials.gov/show/NCT02087319 Completed China Medical University Hospital 2015-06-30
NCT02067260 A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males https://ClinicalTrials.gov/show/NCT02067260 Completed Spencer Forrest, Inc. 2010-04-30
NCT01309191 Microarray Analysis of Scalp Biopsies After Minoxidil Treatment https://ClinicalTrials.gov/show/NCT01309191 Completed University Hospitals Cleveland Medical Center 2012-04-30
NCT01286649 Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT01286649 Completed RepliCel Life Sciences, Inc. 2012-04-30
NCT02037191 The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade https://ClinicalTrials.gov/show/NCT02037191 Completed University Hospital, Rouen 2017-12-31
NCT02018042 An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata https://ClinicalTrials.gov/show/NCT02018042 Completed Columbia University 2017-07-31
NCT02014584 Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT02014584 Completed GlaxoSmithKline 2016-03-19
NCT01986140 Scalp Cooling to Prevent Chemo-induced Hair Loss https://ClinicalTrials.gov/show/NCT01986140 Active, not recruiting Baylor Breast Care Center 2017-02-10
NCT01967277 A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy https://ClinicalTrials.gov/show/NCT01967277 Completed Capillus, LLC 2014-08-31
NCT01950780 Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata https://ClinicalTrials.gov/show/NCT01950780 Completed Columbia University 2016-04-30
NCT01929330 Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT01929330 Completed GlaxoSmithKline 2014-01-09
NCT04450602 A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss https://ClinicalTrials.gov/show/NCT04450602 Completed Arbor Life Labs 2018-10-20
NCT04450589 A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss https://ClinicalTrials.gov/show/NCT04450589 Completed Arbor Life Labs 2018-10-23
NCT01904721 A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) https://ClinicalTrials.gov/show/NCT01904721 Completed Allergan 2014-09-30
NCT01900041 A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss https://ClinicalTrials.gov/show/NCT01900041 Completed Merz Pharmaceuticals GmbH 2013-05-31
NCT03351322 ENERGI-F701 for Female Hair Loss Treatment https://ClinicalTrials.gov/show/NCT03351322 Recruiting Energenesis Biomedical Co., Ltd. 2019-10-03
NCT01852487 Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT01852487 Completed Dream Plus 2012-12-31
NCT01831791 A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT01831791 Completed GlaxoSmithKline 2014-07-19
NCT01831024 Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia https://ClinicalTrials.gov/show/NCT01831024 Active, not recruiting Target Health Inc. 2020-10-31
NCT01797432 Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT01797432 Completed University of Minnesota 2014-11-30
NCT01701271 Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females https://ClinicalTrials.gov/show/NCT01701271 Completed Mexis George 2001-06-30
NCT01669746 A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) https://ClinicalTrials.gov/show/NCT01669746 Completed Aderans Research Institute 2013-04-30
NCT01559584 Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT01559584 Completed Cairo University 2014-03-31
NCT01520077 Vytorin in the Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT01520077 Completed University of Miami 2015-01-31
NCT01325337 Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia https://ClinicalTrials.gov/show/NCT01325337 Completed Allergan 2012-08-31
NCT01453686 A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata https://ClinicalTrials.gov/show/NCT01453686 Completed The Hospital for Sick Children 2003-08-31
NCT01451190 A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) https://ClinicalTrials.gov/show/NCT01451190 Completed Aderans Research Institute 2013-03-31
NCT01451177 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) https://ClinicalTrials.gov/show/NCT01451177 Completed Aderans Research Institute 2012-01-31
NCT01451151 A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) https://ClinicalTrials.gov/show/NCT01451151 Completed Aderans Research Institute 2012-06-30
NCT01451138 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) https://ClinicalTrials.gov/show/NCT01451138 Completed Aderans Research Institute 2012-10-31
NCT01451125 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) https://ClinicalTrials.gov/show/NCT01451125 Completed Aderans Research Institute 2012-03-31
NCT01451112 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) https://ClinicalTrials.gov/show/NCT01451112 Completed Aderans Research Institute 2012-08-31
NCT01451099 A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss https://ClinicalTrials.gov/show/NCT01451099 Completed Aderans Research Institute 2010-09-30
NCT01451073 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) https://ClinicalTrials.gov/show/NCT01451073 Completed Aderans Research Institute 2010-08-31
NCT01451047 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) https://ClinicalTrials.gov/show/NCT01451047 Completed Aderans Research Institute 2011-04-30
NCT01437163 Treatment of Androgenetic Alopecia in Males and Females https://ClinicalTrials.gov/show/NCT01437163 Completed Apira Science, Inc. 2013-08-31
NCT01391156 Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss https://ClinicalTrials.gov/show/NCT01391156 Completed Mae Fah Luang University Hospital 2012-03-31
NCT04435847 Safety and Efficacy of HST 001 in Male Pattern Hair Loss https://ClinicalTrials.gov/show/NCT04435847 Recruiting Histogen 2021-01-31
NCT04412148 Modified SALT Score for Alopecia Areata https://ClinicalTrials.gov/show/NCT04412148 Recruiting Kasr El Aini Hospital 2020-07-01
NCT04409041 Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia https://ClinicalTrials.gov/show/NCT04409041 Active, not recruiting Washington University School of Medicine 2020-12-31
NCT04346316 A Phase II Study in Patients With Alopecia Areata https://ClinicalTrials.gov/show/NCT04346316 Recruiting Reistone Biopharma Company Limited 2021-07-31
NCT04299503 Topical Crisaborole in Patients With Alopecia Areata https://ClinicalTrials.gov/show/NCT04299503 Recruiting Tufts Medical Center 2021-03-31
NCT04238091 Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata https://ClinicalTrials.gov/show/NCT04238091 Recruiting Columbia University 2022-12-31
NCT04228029 Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids https://ClinicalTrials.gov/show/NCT04228029 Active, not recruiting Kasr El Aini Hospital 2020-02-20
NCT04209803 N-Acetyl-Cysteine for Treatment of AGA in Men https://ClinicalTrials.gov/show/NCT04209803 Recruiting Kafrelsheikh University 2020-09-30
NCT04207931 Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study https://ClinicalTrials.gov/show/NCT04207931 Recruiting Wake Forest University Health Sciences 2021-11-30
NCT04205214 A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia https://ClinicalTrials.gov/show/NCT04205214 Active, not recruiting City, University of London 2019-12-13
NCT04090801 Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss https://ClinicalTrials.gov/show/NCT04090801 Completed Sohag University 2016-05-30
NCT04048031 Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning Hair https://ClinicalTrials.gov/show/NCT04048031 Recruiting Ablon Skin Institute Research Center 2021-01-31
NCT04034134 Jaktinib Dihydrochloride Monohydrate in Severe Alopecia Areata https://ClinicalTrials.gov/show/NCT04034134 Recruiting Suzhou Zelgen Biopharmaceuticals Co.,Ltd 2020-09-01
NCT04019795 Modulated Light Therapy in Participants With Pattern Hair Loss https://ClinicalTrials.gov/show/NCT04019795 Completed PhotonMD, Inc 2019-05-25
NCT04006457 Long-Term PF-06651600 for the Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT04006457 Recruiting Pfizer 2023-05-01
NCT04003376 Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata https://ClinicalTrials.gov/show/NCT04003376 Recruiting Assiut University 2021-07-01
NCT03941548 Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata https://ClinicalTrials.gov/show/NCT03941548 Active, not recruiting Concert Pharmaceuticals 2020-03-31
NCT03938948 Low Level Light Therapy (LLLT) for Hair Growth https://ClinicalTrials.gov/show/NCT03938948 Recruiting Awareable Technologies Inc 2020-12-31
NCT03899259 A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata https://ClinicalTrials.gov/show/NCT03899259 Recruiting Eli Lilly and Company 2021-02-05
NCT03898479 Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata https://ClinicalTrials.gov/show/NCT03898479 Active, not recruiting Concert Pharmaceuticals 2022-02-28
NCT03873155 The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata https://ClinicalTrials.gov/show/NCT03873155 Completed University of Sheffield 2019-08-20
NCT03852992 Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT03852992 Recruiting University of Minnesota 2021-07-01
NCT03847441 Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT03847441 Completed Aswan University Hospital 2018-12-31
NCT03831334 Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia https://ClinicalTrials.gov/show/NCT03831334 Recruiting Northwestern University 2020-12-31
NCT03811912 Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata https://ClinicalTrials.gov/show/NCT03811912 Completed Concert Pharmaceuticals 2019-11-21
NCT03753113 Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5% https://ClinicalTrials.gov/show/NCT03753113 Completed Tabriz University of Medical Sciences 2019-09-02
NCT03742518 A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT03742518 Active, not recruiting Samumed LLC 2021-01-31
NCT03712696 Efficacy and Safety of DIGNICAPâ„¢ System https://ClinicalTrials.gov/show/NCT03712696 Completed European Institute of Oncology 2018-04-30
NCT03709563 Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss https://ClinicalTrials.gov/show/NCT03709563 Active, not recruiting DeNova Research 2020-07-02
NCT03689452 The Effect of Platelet Rich Plasma on Non-scarring Alopecia https://ClinicalTrials.gov/show/NCT03689452 Completed Icahn School of Medicine at Mount Sinai 2019-06-03
NCT03676400 Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia https://ClinicalTrials.gov/show/NCT03676400 Completed Medipost Co Ltd. 2019-07-22
NCT03651752 DPCP for the Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT03651752 Recruiting University of Minnesota 2020-09-01
NCT03630198 Pain Outcomes Following Intralesional Corticosteroid Injections https://ClinicalTrials.gov/show/NCT03630198 Recruiting Vanderbilt University Medical Center 2019-09-30
NCT03594227 ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis https://ClinicalTrials.gov/show/NCT03594227 Completed Aclaris Therapeutics, Inc. 2019-06-06
NCT03570749 A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata https://ClinicalTrials.gov/show/NCT03570749 Active, not recruiting Eli Lilly and Company 2021-02-11
NCT03551821 Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata https://ClinicalTrials.gov/show/NCT03551821 Completed Aclaris Therapeutics, Inc. 2018-11-06
NCT03535233 Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT03535233 Completed Cairo University 2017-06-30
NCT03521687 Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA) https://ClinicalTrials.gov/show/NCT03521687 Recruiting Icahn School of Medicine at Mount Sinai 2019-10-15
NCT03495817 A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution https://ClinicalTrials.gov/show/NCT03495817 Active, not recruiting Aclaris Therapeutics, Inc. 2019-10-30
NCT03491267 Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis https://ClinicalTrials.gov/show/NCT03491267 Enrolling by invitation Johns Hopkins University 2025-12-31
NCT03488108 Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women https://ClinicalTrials.gov/show/NCT03488108 Completed Mayo Clinic 2018-05-31
NCT03422640 Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia https://ClinicalTrials.gov/show/NCT03422640 Recruiting Bellevue Dermatology 2019-01-31
NCT01246284 The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT01246284 Completed University of British Columbia 2014-07-31
NCT01231607 Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT01231607 Completed GlaxoSmithKline 2012-02-01
NCT01226459 Clinical Trial in Females for Female Pattern Hair Loss https://ClinicalTrials.gov/show/NCT01226459 Completed Johnson & Johnson Consumer and Personal Products Worldwide 2011-08-31
NCT01189279 Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia https://ClinicalTrials.gov/show/NCT01189279 Completed Allergan 2011-01-31
NCT01167946 Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata https://ClinicalTrials.gov/show/NCT01167946 Completed King Saud University 2009-12-31
NCT01145625 Clinical Trial in Females With Female Pattern Hair Loss https://ClinicalTrials.gov/show/NCT01145625 Completed Johnson & Johnson Consumer and Personal Products Worldwide 2012-02-29
NCT01052870 Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT01052870 Completed HairDx, LLC 2009-12-31
NCT01023841 Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children https://ClinicalTrials.gov/show/NCT01023841 Completed Allergan 2012-11-02
NCT01016964 Treatment of Androgenetic Alopecia in Females, 12 Beam https://ClinicalTrials.gov/show/NCT01016964 Completed Lexington International, LLC 2011-03-31
NCT01008774 START: Swiss Taxotere Alopecia Prevention Trial https://ClinicalTrials.gov/show/NCT01008774 Completed Sanofi 2011-10-31
NCT00997815 The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis https://ClinicalTrials.gov/show/NCT00997815 Completed Siriraj Hospital 2010-12-31
NCT00981461 Treatment of Androgenetic Alopecia in Females, 9 Beam https://ClinicalTrials.gov/show/NCT00981461 Completed Lexington International, LLC 2010-10-31
NCT00965640 Treatment of Male Pattern Baldness With Botulinum Toxin https://ClinicalTrials.gov/show/NCT00965640 Completed The Crown Institute 2004-06-30
NCT00958750 Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT00958750 Completed Charite University, Berlin, Germany 2009-02-28
NCT00947505 Treatment of Androgenetic Alopecia in Males https://ClinicalTrials.gov/show/NCT00947505 Completed Lexington International, LLC 2010-08-31
NCT00947219 Treatment of Androgenic Alopecia in Males https://ClinicalTrials.gov/show/NCT00947219 Completed Lexington International, LLC 2010-08-31
NCT03800979 Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata https://ClinicalTrials.gov/show/NCT03800979 Active, not recruiting Institute of Dermatology, Thailand 2020-09-30
NCT01590238 Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM) https://ClinicalTrials.gov/show/NCT01590238 Completed The New York Eye & Ear Infirmary 2013-09-30
NCT01451021 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss https://ClinicalTrials.gov/show/NCT01451021 Completed Aderans Research Institute 2010-06-30
NCT01319370 Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT01319370 Completed Charite University, Berlin, Germany 2013-03-31
NCT02350023 Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata https://ClinicalTrials.gov/show/NCT02350023 Completed Postgraduate Institute of Medical Education and Research 2015-03-31
NCT04147845 Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata https://ClinicalTrials.gov/show/NCT04147845 Recruiting Alexandria University 2020-10-31
NCT00515762 Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling https://ClinicalTrials.gov/show/NCT00515762 Completed Hospital San Carlos, Madrid 2010-06-30
NCT00484679 Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata https://ClinicalTrials.gov/show/NCT00484679 Completed University of Minnesota 2009-06-30
NCT00441116 A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT00441116 Completed GlaxoSmithKline 2008-01-21
NCT00418730 Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss https://ClinicalTrials.gov/show/NCT00418730 Completed Neosil, Inc. 2007-10-31
NCT00408798 Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin https://ClinicalTrials.gov/show/NCT00408798 Completed University of British Columbia 2009-10-30
NCT00396175 Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) https://ClinicalTrials.gov/show/NCT00396175 Completed Merck Sharp & Dohme Corp. 2000-01-31
NCT00187577 Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata https://ClinicalTrials.gov/show/NCT00187577 Completed University of California, San Francisco 2006-02-28
NCT00177021 Aldara for the Treatment of Extensive Alopecia Areata https://ClinicalTrials.gov/show/NCT00177021 Completed University of Minnesota NA
NCT00176982 Plaquenil for Alopecia Areata, Alopecia Totalis https://ClinicalTrials.gov/show/NCT00176982 Completed University of Minnesota 2007-12-31
NCT00176969 Response of Topical Capsaicin in Alopecia Areata https://ClinicalTrials.gov/show/NCT00176969 Completed University of Minnesota NA
NCT00176943 Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% https://ClinicalTrials.gov/show/NCT00176943 Completed University of Minnesota 2002-08-31
NCT00175617 Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss https://ClinicalTrials.gov/show/NCT00175617 Completed University of British Columbia 2009-03-09
NCT00167102 Alefacept in Patients With Severe Scalp Alopecia Areata https://ClinicalTrials.gov/show/NCT00167102 Completed University of Minnesota 2008-02-29
NCT00151515 A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss https://ClinicalTrials.gov/show/NCT00151515 Completed Johnson & Johnson Consumer and Personal Products Worldwide 2004-07-31
NCT00063076 Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata https://ClinicalTrials.gov/show/NCT00063076 Completed M.D. Anderson Cancer Center 2006-10-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02548689 PAI-1 Expression in Non-scarring Hair Loss https://ClinicalTrials.gov/show/NCT02548689 Enrolling by invitation Northwestern University 2020-06-30
NCT02530177 Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer https://ClinicalTrials.gov/show/NCT02530177 Recruiting Memorial Sloan Kettering Cancer Center 2021-08-31
NCT02206802 Minoxidil Response Testing in Females With Female Pattern Hair Loss https://ClinicalTrials.gov/show/NCT02206802 Completed Applied Biology, Inc. 2018-10-31
NCT02198261 Minoxidil Response Testing in Males With Androgenetic Alopecia https://ClinicalTrials.gov/show/NCT02198261 Completed Applied Biology, Inc. 2018-10-31
NCT01295008 Androgenetic Alopecia in Fabry Disease https://ClinicalTrials.gov/show/NCT01295008 Completed Baylor Research Institute 2015-10-31
NCT01328678 A Study of Vitamin D in Subjects With Alopecia Areata https://ClinicalTrials.gov/show/NCT01328678 Completed Avera McKennan Hospital & University Health Center 2011-07-31
NCT04191005 Efficacy of Platelet-Rich Plasma Therapy for Androgenetic Alopecia: A Systematic Review and Meta-analysis https://ClinicalTrials.gov/show/NCT04191005 Recruiting Assiut University 2020-01-20
NCT03694067 Androgenetic Alopecia and the JAK-STAT Pathway https://ClinicalTrials.gov/show/NCT03694067 Completed Cairo University 2019-12-01
NCT01004809 AVODART® Alopecia Post-marketing Surveillance (PMS) https://ClinicalTrials.gov/show/NCT01004809 Completed GlaxoSmithKline 2012-12-01
NCT04379583 HairDx Analytical Validation Study https://ClinicalTrials.gov/show/NCT04379583 Recruiting Applied Biology, Inc. 2020-09-06
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT00691769 Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia https://ClinicalTrials.gov/show/NCT00691769 Completed Wake Forest University Health Sciences 2012-11-26
NCT00069589 Alopecia Areata Registry https://ClinicalTrials.gov/show/NCT00069589 Active, not recruiting M.D. Anderson Cancer Center 2099-11-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03044782 Barriers to Care and QOL for CCCA Patients https://ClinicalTrials.gov/show/NCT03044782 Completed Northwestern University 2017-09-30